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seem to be important factors in the pathogenesis ofParkin and Hsp70 Sacked by BAG5
sporadic PD. The critical role of protein metabolism in
the pathogenesis of PD is best illustrated by the function
of parkin. parkin mutations were first described in a
Loss-of-function mutations in the parkin gene, which group of Japanese patients who developed an autoso-
encodes an E3 ubiquitin ligase, are the major cause mal-recessive form of juvenile parkinsonismwith clinical
of early-onset Parkinson’s disease (PD). In this issue symptoms indistinguishable from idiopathic PD (von
of Neuron, Kalia et al. show that the bcl-2-associated Coelln et al., 2004). Since its discovery, numerous exon
athanogene 5 (BAG5) enhances dopamine neuron deletions, duplications, and point mutations were found
death in an in vivo model of PD through inhibiting the in patients with early-onset PD. In fact, parkinmutations
E3 ligase activity of parkin and the chaperone activity can account for up to 40% of early-onset PD (von Coelln
of Hsp70. et al., 2004). Parkin is an E3 ligase in the ubiquitin system
and functions in the targeting of substrates for proteaso-
mal degradation (von Coelln et al., 2004). It is generallyParkinson’s disease (PD) is a progressive neurodegen-
believed that accumulation of these substrates due toerative disorder characterized by impairment in motor
loss of parkin’s activity can lead to disastrous conse-function including bradykinesia, rest tremor, rigidity, gait
quences for the survival of dopaminergic neurons (vonabnormalities, and postural instability. Pathologically,
Coelln et al., 2004). A number of substrates and inter-PD is marked by the selective loss of dopaminergic
actors of parkin have been described. However, no po-neurons in the substantia nigra pars compacta (SNc)
tential interactor has been identified that can regulateand the presence of Lewy bodies, intracellular protein-
parkin’s function. Up to now, only posttranslationalaceous inclusions (Dawson and Dawson, 2003). Be-
modification through S-nitrosylation and phosphoryla-cause dopaminergic inputs from the SNc are important
tion have been shown to affect the enzymatic activityregulators of corticostriatal neuronal transmission, it is
of parkin (Chung et al., 2004; Yamamoto et al., 2004).believed that such loss leads to the symptoms of PD
In particular, nitrosative stress has been shown to com-through the ultimate impairment of movement-related
promise parkin’s protective function and provides aactivation of the prefrontal motor cortex. The molecular
common pathogenic pathway for both the familial andmechanism of dopaminergic neuronal cell death is not
sporadic forms of PD (Chung et al., 2004).fully understood, but both genetic and environmental
In this issue of Neuron, Kalia et al., show that BAG5components are believed to contribute significantly to
enhances dopaminergic neuronal degeneration throughthe neurodegenerative process (Dawson and Dawson,
inhibition of the E3 ligase activity of parkin and the chap-2003).
erone activity of Hsp70 (Figure 1) (Kalia et al., 2004).In recent years, research in PD has been fueled by the
Moreover, BAG5 enhances the sequestration of parkinidentification of genes that are linked to rare Mendelian
within Lewy body-like aggregates and mitigates parkin-forms of PD. So far, 11 loci have been described, and
mediated preservation of proteasome function and in-5 genes have been linked to familial PD (Greenamyre
hibition of cell death. The human BAG protein familyand Hastings, 2004; Shen, 2004). Mutations and triplica-
contains six members, and all contain a BAG domaintion of -synuclein and mutations in LRRK2/dardarin
(Takayama and Reed, 2001). The first family member,cause autosomal-dominant forms of PD (Greenamyre
BAG1, was identified initially as a Bcl binding proteinand Hastings, 2004; Shen, 2004). On the other hand,
(Bcl-associated athanogene-1) with anti-cell death ac-mutations in parkin, DJ-1, and PINK1 cause autosomal-
tivity (Takayama and Reed, 2001). Soon, it was foundrecessive forms of PD (Greenamyre andHastings, 2004).
that BAG1 could interact with other proteins, includingStudying these genes has been the subject of intense
Hsp70 (Takayama and Reed, 2001). Kalia et al. identifiedfocus with the thought that understanding their function
BAG5 as a gene that is upregulated in the SNc followingwill provide crucial insight into the pathogenesis of the
medial forebrain bundle (MFB) transection (Kalia et al.,more common, sporadic form of PD. For instance, the
2004). Both immunohistochemistry and in situ hybridiza-linkage of -synuclein with familial PD led to the discov-
tion confirm that BAG5 is present in dopaminergic neu-ery that -synuclein is one of the major components
rons in the SNc, and the expression of this gene isof the Lewy body, which provided solid support for a
selectively increased after MFB axotomy. BAG5 inter-common pathogenic mechanism between the familial
acts with Hsp70 and interferes with its function to refoldand sporadic forms of PD (Dawson and Dawson, 2003).
misfolded proteins. The activity of BAG5 is dependentThe roles of DJ-1, PINK1, and LRRK2/dardarin in PD
on its conserved domains, and mutations of these do-are still not clear, but the presence of kinase domains
mains result in the total abrogationof its effect onHsp70.in PINK1 and LRRK2/dardarin suggest that they might
More importantly, BAG5 was found to directly interactbe involved in important signaling cascades (Shen,
with parkin, even in the absence of Hsp70. The interac-2004). The function of DJ-1 is not known, but DJ-1 might
tion between BAG5 and parkin is specific, and the inter-have chaperone activity and possess important protec-
action seems to interfere with the E3 ligase activity oftive properties in the mitochondria when neurons are
parkin. This is particularly striking, as so far, no proteinsexposed to oxidative insults (Bonifati et al., 2004).
Oxidative stress and protein metabolism/mishandling have been identified that can interfere with the normal
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conventional view of Lewy bodies in PD is that they
are deleterious to the survival of dopaminergic neurons
(Olanowet al., 2004). On the other hand, inclusion bodies
may just be thebyproduct of the processof neurodegen-
eration (Olanow et al., 2004). However, some studies,
especially in the field of polyglutamine-induced neuro-
degeneration, as in Huntington’s disease, have revealed
that intracellular inclusions might be the last line of de-
fense against toxic protein species in neurons (Arrasate
et al., 2004). BAG5 seems tomediate its effect on parkin,
in part, by sequestering it to inclusion bodies and hence
ultimately interfering with the normal function of parkin.
If the toxic effect of BAG5 ismediated through the forma-
tion of protein aggregates, overexpression of it in animal
models should result in increased formation of inclusion
bodies along with increased neuronal cell death when
dopaminergic neurons are exposed to different insults.
Finally, the protective function of mutant BAG5 may
provide new approaches for the treatment of PD. The
family of BAG protein is characterized by the presence
of the BAG domain, which possesses the conserved
amino acid residues aspartate and arginine. Mutation
of these residues seems to provide a dominant-negative
Figure 1. Schematic Diagram Illustrating How BAG5 Can Mediate
effect on BAG5 deleterious properties, and this mightIts Deleterious Effect on Neuronal Survival
present a valuable approach for the gene therapyBAG5 interferes with the normal function of parkin and Hsp70, which
against the neurodegenerative process of PD.might ultimately lead to the accumulation of cytotoxic fibrils and
The work by Kalia et al. clearly illustrates the impor-formation of protein aggregates. The consequence is the promotion
of neurodegeneration. tance of studying genes that are linked to familial PD,
as significant advances in the understanding of the
pathogenic mechanisms of PD continue to arise from
these studies. The ultimate challenge will be how weactivity of parkin. BAG5 significantly downregulates par-
can make use of this knowledge in the development ofkin’s E3 ligase activity. BAG5 also seems to mediate its
potential new therapeutic strategies for the treatmenteffect on parkin through the inhibition of the activity of
of PD in the foreseeable future.Hsp70 and sequestering parkin into protein aggregates.
The mechanism of how BAG5 can compromise parkin’s
function is illustrated by the experiment that BAG5 en- Kenny K.K. Chung1,2 and Ted M. Dawson1,2,3
hances proteasomal dysfunction and abrogates par- 1Institute for Cell Engineering
kin’s ability to rescue cell death induced by overexpres- 2Department of Neurology
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proteasomal inhibition. One of the most significant find- Johns Hopkins University School of Medicine
ings is that overexpression of BAG5 through adenovirus Baltimore, Maryland 21205
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von Coelln, R., Dawson, V.L., and Dawson, T.M. (2004). Cell Tissue ment for specific regulation of palmitoylation has driven
Res. 318, 175–184. the search for the PATs that could modulate processes
Yamamoto, A., Friedlein, A., Imai, Y., Takahashi, R., Kahle, P.J., such as neuronal protein trafficking and synaptic plas-
and Haass, C. (2004). J. Biol. Chem., in press. Published online ticity.
November 22, 2004. 10.1074/jbc.M407724200
In this issue of Neuron, both Fukata et al. (2004) and
Huang et al. (2004) describe the properties of recently
identified PATs and specifically look at their abilities
to palmitoylate synaptic proteins (of which the most
prominent is debatably the postsynaptic scaffoldingGreasing Transmission:
protein, PSD-95). Fukata et al. took a genomic approachPalmitoylation at the Synapse and determined all the possible PATs in the mouse ge-
nome based on the presence of a DHHC motif. This
sequence of amino acids (single-letter code) was deter-
mined to be required for activity in yeast PATs and wasPosttranslationalmodifications such as palmitoylation
identified by a forward genetic approach (Linder andhave the ability to modulate protein localization and
Deschenes, 2004). Fukata and coworkers isolated a totalfunction. The reversible addition of the fatty acid pal-
of 23 different mouse PATs which they name DHHC-1mitate to proteins has been known to occur in neurons
through -23. These were then tested for their ability tofor a considerable amount of time and has been no-
palmitoylate PSD-95 in transfected nonneuronal cells,ticed to be of particular importance at synapses. In
in a cell-free assay and in neurons. DHHC-2, -3, -7, andthis issue of Neuron, Huang et al. and Fukata et al.
-15 showed the strongest specificity for PSD-95. Theydescribe their studies of palmitoyl transferases and
further described the differing specificities of these en-how these enzymes specifically catalyze themodifica-
zymes for other palmitoylated proteins, such as GAP-tion of a number of synaptic proteins, including the
43, SNAP-25, Lck, Gs, and H-ras.postsynaptic scaffolding protein PSD-95.
To determine an effect of palmitoylation of PSD-95,
they investigated the ability of the PSD-95 PATsOnce proteins have been synthesized on free ribosomes
(P-PATs) to change the distribution of PSD-95 from aor on rough ER, they have the potential to be modified
diffuse pattern to a distinctly perinuclear localization.by a series of posttranslational additions, such as phos-
Since DHHC-15 showed the greatest increase in palmi-phorylation, ubiquitination, glycosylation, acetylation,
toylation of PSD-95, they chose this as their favorite andand lipid modification. Lipid modifications can include
mutated this P-PAT to eliminate its palmitloyl trans-the addition of myristoyl, prenyl, and palmitoyl moieties
ferase activity. They thereby noticed that mutations atto the protein. Lipid modifications increase the overall
the active site of this enzyme transform these mutantshydrophobicity of the protein and can thereby facilitate
into dominant-negative forms. They proceeded to takethe interaction of proteins with cellular membranes. The
advantage of these dominant-negative DHHC-15 mole-addition of palmitic acid to proteins in neurons has long
cules to demonstrate that palmitoylation by this P-PAT
been known (Bizzozero, 1997).
is indeed important for the punctate localization of PSD-
More recently, palmitoylation has specifically been
95 and the surface localization of AMPA receptor GluR1.
shown to play a role in axon pathfinding, neuronal pro-
In contrast, Huang et al. concentrated on one PAT
tein trafficking, and the clustering of receptors and asso- which was cloned by virtue of its interaction with hunt-
ciated scaffolding proteins at synapses (El-Husseini and ingtin and aptly named HIP14 (huntingtin-interacting
Bredt, 2002). Also, this modification has been well de- protein). Due to the presence of a DHHC motif, they
scribed for a number of presynaptic proteins, including surmised that it may be aPAT and described its specific-
the SNARE proteins VAMP, SNAP-25, and synaptotag- ity for a number of synaptic proteins. It was shown to
min, which are involved in synaptic vesicle fusion (Veit palmitoylate PSD-95, SNAP-25, synaptotagmin I, hunt-
et al., 1996, 2000). Despite the huge importanceof palmi- ingtin, and GAD65. HIP14 did not demonstrate enzy-
toylation on function in the nervous system, it was only matic activity toward H-ras, paralemmin, Lck, or synap-
in the last couple of years that the enzymes that catalyze totagmin VII. They also proceeded to use the same
the transfer of palmitate, palmitoyl transferases (or localization assay as Fukata et al., by which they investi-
PATs), were described in yeast (Linder and Deschenes, gated the correlation of enzymatic activity and the ability
2004). Palmitate is transferred from Coenzyme A to spe- to cause proteins to localize to a distinct perinuclear
cific cysteine residues in prettymuch any location within milieu. EM and immunocytochemistry demonstrated lo-
the amino acid sequence of a huge variety of proteins. calization of HIP14 predominantly to the Golgi appara-
Proteins that are modified range from small cytosolic tus, although immunogold particles were also seen at
proteins (e.g., H-ras) to large transmembrane receptors tubulovesicular organelles in dendrites, axons, and
(e.g., GABA-A receptor) to secreted factors (e.g., sonic spine necks. Live imaging showed trafficking of HIP14
hedgehog). The cysteine residue to which the C16 fatty together with clusters of SNAP25. To determine a re-
acid chain is added is highly reactive and, in fact, this quirement of palmitoylation by HIP14 for the punctate
modification can occur in vitro without the need for an distribution of PSD-95, rather than using a dominant-
enzyme (Veit, 2000). The thioester bond that is formed negative, Huang and coworkers used siRNA to effec-
is labile and thus reversible. It has been shown that tively knock down the level of HIP14 in neurons (see
regulation of the extent of palmitoylation is required to Figure 1).
control a number of processes during development and While both of these studies elegantly demonstrate the
catalysis of palmitoylation of PSD-95 and its require-signaling (El-Husseini and Bredt, 2002). This require-
